Biological Effects of Agent on PAR-4 Levels With Resected Solid Tumors
Hydroxychloroquine will be administered on an outpatient basis within 12 weeks after primary surgery followed by adjuvant chemotherapy /or radiation therapy (if needed). Hydroxychloroquine will be administered orally at a dose of 400 mg daily for 90 days. Subjects will receive HCQ every day.
Solid Tumor
DRUG: Hydroxychloroquine
PAR-4 increase, Proportion of patients exhibiting a four-fold increase in PAR-4 levels, 3 months
Complete Serological Response, Rate of complete serological response in prostate cancer, 12 months|Progression free survival, Progression free survival in other resected solid tumors, 12 months
Hydroxychloroquine will be administered on an outpatient basis within 12 weeks after primary surgery followed by adjuvant chemotherapy /or radiation therapy (if needed). Hydroxychloroquine will be administered orally at a dose of 400 mg daily for 90 days. Subjects will receive HCQ every day.